ERFSF (Life Sciences Tools & Services) Stock Valuation & Fair Value Fairly valued
ERFSF (Life Sciences Tools & Services) trades at a blended P/E of 19.5, about 35% below its historical normal valuation, with a forward growth estimate of 12.0% and a PEG of 1.62. Analysts' one-year estimates have been hit 45% of the time.
No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.
Valuation flags
- No notable valuation flags.
Verdict history
tickerseer's rating has been fairly valued since 2026-09-19.
Ratings recorded live since 2026-09-21. Earlier points apply today's valuation rules to the metrics tickerseer archived that week.
Frequently asked questions
Is ERFSF overvalued?
At a blended P/E of 19.5 versus its historical normal P/E of 29.9, ERFSF trades about 35% below its typical valuation, with a PEG of 1.62 on 12.0% forward growth. tickerseer currently rates it fairly valued.
What is ERFSF's fair value and PEG?
ERFSF trades at a blended P/E of 19.5 against a historical normal P/E of 29.9, a PEG of 1.62, and a forward growth estimate of 12.0%.
Has tickerseer's rating of ERFSF changed?
tickerseer's rating has been fairly valued since 2026-09-19.
Industry: Life Sciences Tools & Services. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.